Back to Agenda
Session 6: DIAmond Session: The Safety Pulse Continues. Executive Perspectives on PV Talent, Technology, and Regulation
Session Chair(s)
Jamie Wilkins, PharmD
Head, Risk Management Center of Excellence, AstraZeneca, United States
This fireside chat brings back senior PV leadership to tackle the field's most pressing questions. Panelists will share how they are building resilient organizations, developing talent, applying AI across safety operations, and adapting to shifting expectations from FDA, EMA, and other regulators. Alongside these themes, panelists will share the career decisions and inflection points that shaped their own paths to safety leadership, and what it looks like for safety to operate as a strategic, value-adding function rather than a purely compliance-driven one.
Learning Objective :
At the conclusion of this session, participants should be able to:
- Identify current challenges and opportunities in global PV, pharmacoepidemiology, RWE, and clinical safety, including AI and evolving regulations.
- Contrast pharmacovigilance leadership approaches and structures across company sizes.
- Describe strategies for positioning safety as a value-adding function, not just compliance.
Have an account?